Explore the revolutionary impact of transcatheter aortic valve replacement (TAVR) on aortic stenosis treatment in this informative lecture by UCLA interventional cardiologist Dr. Olcay Aksoy. Gain insights into the prevalence, risk factors, diagnosis, and classification of aortic stenosis. Learn about the TAURUS PARTNER Study, potential risks associated with TAVR, and key takeaways for intermediate-risk patients. Discover the procedure's details, including conscious sedation and the team involved. Understand how TAVR is shaping the future of cardiovascular care and improving patient outcomes. Conclude with a Q&A session to address specific concerns and deepen your understanding of this groundbreaking treatment approach.
Overview
Syllabus
Introduction
Agenda
How common is aortic stenosis
Agerelated calcification
Risk factors
Diagnosis
Classification
Prognosis
Survival
Not all patients get surgery
Age is not a contraindication
What is TAURUS
PARTNER Study
Risk of Stroke
Risk of Vascular Complication
Power of Leak
Key takeaways
Intermediate risk
Conscious sedation
Before and after
Procedure
Who is involved
Future is bright
Patients
Team
Questions
Taught by
UCLA Health
Tags
Related Courses
-
TAVR and the Lifetime Management of Aortic Stenosis - Grand Rounds 1.26.23
-
State-of-the-Art Aortic Stenosis - Dr. William Suh, MD | UCLA Primary Care Update 2015
-
Transcatheter Aortic Valve Replacement (TAVR) - Minimally Invasive Treatment for Aortic Stenosis
-
Transcatheter Aortic Valve Replacement and Mitraclip - The Science Behind It
-
TAVR in Bicuspid Aortic Stenosis
-
Management of Aortic Stenosis - William Suh, MD - UCLA Health
